Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T03046 | Target Info | |||
Target Name | Mutated KRAS (mKRAS) | ||||
Synonyms | c-Ki-ras (mutated); c-K-ras (mutated); RASK2 (mutated); Ki-Ras (mutated); KRAS2 (mutated); K-Ras 2 (mutated); GTPase KRas (mutated) | ||||
Target Type | Clinical trial Target | ||||
Gene Name | KRAS | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | [(2~{R})-6-chloranyl-2,3-dihydro-1,4-benzodioxin-2-yl]methanamine | Ligand Info | |||
Canonical SMILES | C1C(OC2=C(O1)C=C(C=C2)Cl)CN | ||||
InChI | 1S/C9H10ClNO2/c10-6-1-2-8-9(3-6)12-5-7(4-11)13-8/h1-3,7H,4-5,11H2/t7-/m1/s1 | ||||
InChIKey | OGSHRCYGTQQEAO-SSDOTTSWSA-N | ||||
PubChem Compound ID | 73424803 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 5OCG Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method. | ||||||
Method | X-ray diffraction | Resolution | 1.48 Å | Mutation | Yes | [1] |
PDB Sequence |
STEYKLVVVG
10 ADGVGKSALT20 IQLIQNHFVD30 EYDPTIEDSY40 RKQVVIDGET50 CLLDILDTAG 60 QEEYSAMRDQ70 YMRTGEGFLC80 VFAINNTKSF90 EDIHHYREQI100 KRVKDSEDVP 110 MVLVGNKCDL120 PSRTVDTKQA130 QDLARSYGIP140 FIETSAKTRQ150 GVDDAFYTLV 160 REIRKHKEKM170 SK
|
|||||
|
||||||
PDB ID: 5OCT Discovery of small molecules binding to KRAS via high affinity antibody fragment competition method. | ||||||
Method | X-ray diffraction | Resolution | 2.07 Å | Mutation | Yes | [1] |
PDB Sequence |
YFQGMTEYKL
6 VVVGAGGVGK16 SALTIQLIQN26 HFVDEYDPTI36 EDSYRKQVVI46 DGETLLDILD 57 TAGHEEYSAM67 RDQYMRTGEG77 FLCVFAINNT87 KSFEDIHHYR97 EQIKRVKDSE 107 DVPMVLVGNK117 CDLPSRTVDT127 KQAQDLARSY137 GIPFIETSAK147 TRQGVDDAFY 157 TLVREIRKHK167 E
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment. Nat Commun. 2018 Aug 9;9(1):3169. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.